Distinct Pathways, Shared Progress: Metabolic/Genetic Disorders & Biliary Physiology

Nov 09 2025
Convention Center: Room 145, Level 1
8:00 AM - 9:30 AM

World Class Speakers

Michael L Schilsky, MD, FAASLD
Moderator

Michael L Schilsky, MD, FAASLD

Yale University Medical Center
Grace L Guo, MBBS, PhD
Moderator

Grace L Guo, MBBS, PhD

Rutgers University

Description

This session highlights innovations from molecular mechanisms to drug development and clinical trials in biliary physiology and genetic and metabolic conditions. This session will spotlight cholangiocyte biology from scaffolding to repair. These research presentations will provide insights into mechanisms and therapeutics for A1AT deficiency, Wilson Disease, and hemachromatosis. 

Journey Maps

Objectives

  • Evaluate emerging therapies for metabolic and genetic liver disease.
  • Describe basic science mechanisms of cholangiocyte development and repair and their implications for therapeutic targets.
  • Discuss basic, translational, and clinical studies for treatment of biliary disorders and genetic/metabolic liver disease.